BioTrace Medical
Menlo Park, US · Delaware corporation · 2 known investors
The page presents cardiac interventional and electrophysiology products—including transseptal sheaths and needles, occlusion balloons, guiding sheaths, guidewires, hemostasis valves, and compression devices—branded under Merit Medical for use in procedures such as lead extraction, cardiac resynchronization therapy, and CRM implantations. The products are aimed at electrophysiologists and cardiac care clinicians.
Founders & leadership
SS
Sharon Stevenson, DVM, PhDDirector
LN
Laura N. DietchExecutive Officer, Director
AS
Aravind Swaminathan, MDDirector
DH
Drew HoffmannDirector
RB
Robert BrownellDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$10.9MraisedMar 2021 · 19 investors · Other Health CareRule 506(b)
▶$10.9MraisedMar 2021 · 19 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Laura N, DietchExecutive Officer, Director
- Drew HoffmannDirector
- Aravind SwaminathanExecutive Officer, Director
- Robert BrownellDirector
- Sharon StevensonDirector
- Ronald MizrahiDirector
- Shilen PatelDirector
- Offering amount
- $16.3M
- Amount sold
- $10.9M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.7MraisedMay 2017 · 9 investors · Other Health CareRule 506(b)
▶$5.7MraisedMay 2017 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Robert BrownellDirector
- Drew HoffmannDirector
- Aravind Swaminathan, MDExecutive Officer, Director
- Laura N. DietchExecutive Officer, Director
- Adam HenickDirector
- Sharon Stevenson, DVM, PhDDirector
- Offering amount
- $8.3M
- Amount sold
- $5.7M
- Minimum investment
- $1
- First sale
- May 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$1.7MraisedJul 2015 · 6 investors · Other Health CareRule 506(b)
▶$1.7MraisedJul 2015 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Sharon Stevenson, DVM, PhDDirector
- Laura N. DietchExecutive Officer, Director
- Aravind Swaminathan, MDDirector
- Drew HoffmannDirector
- Robert BrownellDirector
- Offering amount
- $1.9M
- Amount sold
- $1.7M
- Minimum investment
- $1
- First sale
- Jul 2015
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.